Gene Mutations Versus Clinically Relevant Phenotypes: Lyso-Gb3 Defines Fabry Disease
暂无分享,去创建一个
M. Beer | B. Bijnens | C. Wanner | F. Weidemann | A. Rolfs | G. Ertl | S. Störk | M. Niemann | F. Breunig
[1] M. Kaps,et al. Frequency of Fabry disease in patients with small‐fibre neuropathy of unknown aetiology: a pilot study , 2011, European journal of neurology.
[2] A. Zwinderman,et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. , 2010, Biochimica et biophysica acta.
[3] T. Kitagawa,et al. Plasma globotriaosylsphingosine as a biomarker of Fabry disease. , 2010, Molecular genetics and metabolism.
[4] F. Weidemann,et al. Screening for Fabry disease using genetic testing , 2010, European journal of heart failure.
[5] C. Wanner,et al. A validated disease severity scoring system for Fabry disease. , 2010, Molecular genetics and metabolism.
[6] J. M. Aerts,et al. Screening for Fabry disease in high-risk populations: a systematic review , 2009, Journal of Medical Genetics.
[7] M. Beer,et al. Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy Evidence for a Better Outcome With Early Treatment , 2009 .
[8] R. Brady,et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease , 2008, Proceedings of the National Academy of Sciences.
[9] J. Sandstede,et al. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. , 2005, European heart journal.
[10] A. Mehta,et al. Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey , 2005, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[11] G. Linthorst,et al. Remarkable variability in renal disease in a large Slovenian family with Fabry disease , 2004, European Journal of Human Genetics.
[12] S. Yonezawa,et al. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease]. , 2004, Journal of cardiology.
[13] R. Desnick,et al. Fabry disease: Characterization of α‐galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele , 2003, Human mutation.
[14] R. Desnick,et al. Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma. , 2003, Molecular genetics and metabolism.
[15] A. Sessa,et al. ‘Atypical’ Clinical Variants of Anderson-Fabry Disease , 2001, Nephron.
[16] R. Schiffmann,et al. Identification of fifteen novel mutations and genotype–phenotype relationship in Fabry disease , 2001, Clinical genetics.
[17] D. Newburg,et al. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3. , 1992, The Journal of infectious diseases.
[18] C. Eng,et al. An atypical variant of Fabry's disease with manifestations confined to the myocardium. , 1991, The New England journal of medicine.
[19] R. Desnick,et al. Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human alpha-galactosidase A suggests evolution from a common ancestral gene. , 1990, The Journal of biological chemistry.
[20] C. Lingwood,et al. Neutralization receptor-based immunoassay for detection of neutralizing antibodies to Escherichia coli verocytotoxin 1 , 1990, Journal of clinical microbiology.
[21] C. Lingwood,et al. Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin , 1989, Journal of Clinical Microbiology.
[22] R. Desnick,et al. Nucleotide sequence of the human a-galactosidase A gene , 1989 .
[23] R. Desnick,et al. Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Desnick,et al. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. , 1973, The Journal of laboratory and clinical medicine.
[25] 寺口 博幸. Terminal stage cardiac findings in patients with cardiac Fabry disease : an electrocardiographic, echocardiographic, and autopsy study , 2008 .
[26] A. Gal,et al. Genotype–phenotype correlation in Fabry disease , 2006 .
[27] A. Mehta,et al. Genotype–phenotype correlation in Fabry disease -- Fabry Disease: Perspectives from 5 Years of FOS , 2006 .
[28] R. Desnick,et al. Nucleotide sequence of the human alpha-galactosidase A gene. , 1989, Nucleic acids research.